Drug Shortage Report for IRBESARTAN
Report ID | 66692 |
Drug Identification Number | 02385295 |
Brand name | IRBESARTAN |
Common or Proper name | IRBESARTAN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-12-14 |
Actual start date | 2018-12-14 |
Estimated end date | 2018-12-18 |
Actual end date | 2018-12-19 |
Shortage status | Resolved |
Updated date | 2018-12-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2018-12-21 | French | Compare |
v11 | 2018-12-21 | English | Compare |
v10 | 2018-12-17 | French | Compare |
v9 | 2018-12-17 | English | Compare |
v8 | 2018-12-15 | English | Compare |
v7 | 2018-12-10 | French | Compare |
v6 | 2018-12-10 | English | Compare |
v5 | 2018-12-08 | English | Compare |
v4 | 2018-12-03 | French | Compare |
v3 | 2018-12-03 | English | Compare |
v2 | 2018-11-12 | French | Compare |
v1 | 2018-11-12 | English | Compare |
Showing 1 to 12 of 12